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Abstract 
‘Prohormone thiol protease’ (PTP) represents the major enkephalin precursor processing activity in chromaflin granules. In this study, cleavage 
specihcity of PTP for paired basic and monobasic residues was examined with a series of model peptide-MCA (-methylcoumarinamide) substrates. 
Monobasic peptides were cleaved at the COOH- and NH,-terminal sides of the single basic residue. Dibasic peptides, however, were preferentially 
cleaved at the NH,-terminal side of the pair, or between the two basic residues, with low cleavage at the CGGH-terminal side of the pair. Inhibition 
by the peptide inhibitor (n-Tyr)-Glu-Phe-Lys-Arg-CH,CI provided further evidence for PTP’s specificity for the dibasic Lys-Arg site. Inhibition by 
Z-Lcu-Val-Gly-CHN, and Z-Arg-Leu-Val-Gly-CHNN, suggests involvement of Val-Gly in substrate binding to PTP; these two cystatin C-related 
inhibitors also indicate PTP as a cysteine protease. These results demonstrate PTP’s unique cleavage specificity that differs from other processing 
endopeptidases, including the subtilisin-related proprotein convertases, PCliPC3, and PC2, as well as the pituitary proopiomelanocortin-converting 
enzyme, PCE. This study provides further evidence for PTP as a novel prohormone processing enzyme that belongs to the class of cysteine proteases. 
Key work Prohorrnone processing; Cysteine protease; Proenkephalin; Neuropeptide; Peptide-MCA 
1. Introduction 
Investigation of proenkephalin processing with recom- 
binant enkephalin precursor has resulted in the identifi- 
cation and purification of a novel ‘prohormone thiol 
protease’ (PTP) that represents the major processing en- 
zyme activity for production of (Met)enkephalin in adre- 
nal medullary chromaffin granules [l-3]. PTP is a single- 
chain 33 kDa glycoprotein with a p1 of 6.0, and a pH 
optimum of pH 5.5. PTP’s requirement for dithiothreitol 
(DTT) and inhibition by iodoacetate, p-hydroxymercu- 
ribenzoate, mercuric chloride, and cystatin C, indicate 
that PTP is a cysteine protease [11. In vitro processing of 
recombinant enkephalin precursor by PTP resembles 
proenkephalin processing in vivo, with production of 
multiple high molecular weight intermediates that pos- 
sess the NH,-terminal segment of the precursor [l]. Im- 
portantly, PTP cleaves the enkephalin-containing inter- 
mediates, BAM-22P, peptide E, and peptide F, at paired 
basic and monobasic residues to generate the final 
(Met)enkephalin product [l-3]. Of interest was the find- 
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zoyl; Boc-, tert-butoxycarbonyl; Bz-, benzoyl; DTT, dithiothreitol; PC, 
proprotein convertase. 
ing that PTP cleaved at the NH,-terminal side of paired 
basic residues, as well as between the two basic residues 
of the pair. In contrast, other prohormone processing 
enzymes, including the proprotein convertases [4] PC1/3 
[5-71 and PC2 [7,8], and the aspartyl protease known as 
‘proopiomelanocortin converting enzyme’ (PCE) [9], 
cleave primarily at the COOH-terminal side or between 
the paired basic residues. To obtain further characteriza- 
tion of PTP cleavage site specificity, this study has exam- 
ined PTP cleavage at dibasic and monobasic sites with 
model peptide-MCA (methylcoumarylamide) substrates, 
and has examined the effects of active site-directed pep- 
tide inhibitors. 
2. Experimental 
2.1. Materials 
Peptide-MCA substrates and AMC (7-amino4methylcoumarin) 
standard were obtained from Peninsula Laboratories (Belmont. CA). 
Hog kidney aminopeptidase M was from Sigma (St. Louis,‘MO). 
(n-Tyr)-Glu-Phe-Lys-Arg-CH,C1 was a gift from Dr. Nabil Seidah at 
the Clinical Research Institute of Montreal, Canada; Z-Leu-Val-Gly- 
CHN, and Z-Arg-Leu-Val-Gly-CHN, were gifts from Dr. A. Grubb at 
the University of Lund, Sweden. 
2.2. PuriJication of PTP 
PTP was purified from chromaffin granules of bovine adrenal me- 
dulla as described previously [l]. Briefly, PTP from isolated chromatlin 
granules was purified by chromatography on concanavalin A-Sepha- 
rose, Sephacryl S200, Polybuffer exchanger 94, and thiolpropyl-Sepha- 
rose [l]. The assay of PTP utilized, as substrate, recombinant enkeph- 
alin precursor in the form of [“S](Met)-preproenkephalin ([35S](Met)- 
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PPE), synthesized from the corresponding cDNA by in vitro transcrip- 
tion and translation as previously described [l,lO]. PTP activity in 
column fractions was detected by measuring the conversion of 
[?S](Met)-PPE to TCA- (trichloroacetic acid) soluble radioactivity as 
described previously [ 1, lo]. 
2.3. PTP cleavage of peptide-MCA substrates 
Enzymatic hydrolysis of peptide-MCA substrates was carried out 
according to the method of Barrett and Kirshke [ 111. Peptide-MCA 
substrates (25 ,uM final concentration) were each incubated with puri- 
fied PTP (5 @assay) at 37’C for 30 min in a total volume of 160 ~1 
PTP assay buffer (0.1 M sodium citrate, pH 5.0, containing 1 mM DTT, 
1 mM EDTA, and 10 mM CHAPS). The reaction was stopped by the 
addition of 10 ,~l of 1% TFA (trifluoroacetic acid) and 2 ml H,O; the 
fluorescent AMC liberated from the peptide-MCA substrate was then 
measured with a Perkin-Elmer 650-40 fluorimeter with excitation and 
emission wavelengths of 385 and 465 nm, respectively. Standard AMC 
was used for quantitation of AMC. 
In some experiments, after incubation of peptide-MCA substrates 
with PTP, the reaction was neutralized with 8 ~1 of 1.5 M Tris-HCl 
buffer, pH 8.8, aminopeptidase M (2 pg) was added, and incubation 
continued for 1 h at 37°C. Reactions were terminated as described 
above and cleavage of peptide-MCA substrates was fluorimetrically 
quantitated by measuring production of AMC. 
2.4. Determination of PTP kinetic constants (I&, and V_,) for 
Z- Phe- A rg-MCA 
Affinity (K,,,) and maximal velocity (V,d of PTP was obtained by 
measuring PTP activity at 1.5-40 PM Z-Phe-Arg-MCA, and by deter- 
mining kinetic constants by a reciprocal Lineweaver-Burk plot of l/[S] 
and l/v [12], where [S] represents ubstrate concentration and v is 
enzyme velocity. 
2.5. Rate of PTP inactivation by peptide inhibitors 
Rates of PTP inactivation by irreversible chloromethyl ketone and 
diazomethane peptide inhibitors (u-Tyr)-Glu-Phe-Lys-Arg-CH,CI, Z- 
Leu-Val-Gly-CHN,, and Z-Arg-Leu-Val-Gly-CHNN,, were determined 
as described by Barrett et al. [13]. PTP (5 t&assay) was incubated with 
inhibitors at pH 5.0 at room temperature; at 5, 10, 15, 20 and 30 min 
time intervals, 6 ~1 aliquots were removed, diluted 1:25 in PTP assay 
buffer, and residual PTP activity was determined by incubation with 
100 PM Z-Phe-Arg-MCA for 30 min at 37°C. Second-order ate con- 
stants (k2) were computed by determining the observed rate of inactiva- 
tion, k, as 0.693/t,,,. The k, was calculated as kl[I], where [II represents 
inhibitor concentration [14,15]. 
Val-Arg-Arg-MCA, a substrate for the processing en- 
zyme furin [17], did not significantly enhance PTP activ- 
ity. PTP cleavage at dibasic and monobasic sites of these 
model peptide-MCA substrates is consistent with PTP 
processing of the enkephalin precursor and enkephalin- 
containing intermediates BAM-22P, peptide E, and pep- 
tide F (Fig. 1). 
It must be noted that this fluorimetric assay does not 
detect peptide-MCA products, since only AMC, and not 
peptide-MCA products, is fluorimetrically detected. 
Thus, while PTP activity with peptide-MCA substrates 
indicates cleavage at the COOH-terminal side of the 
basic residue adjacent to -MCA, cleavages at the NH,- 
terminal side of the basic residue(s) would not be de- 
tected. Therefore, following PTP hydrolysis, aminopep- 
tidase M (APM) was used to convert peptide-MCA 
products to free AMC as a means to detect cleavage at 
the NH,-terminal side of basic residue(s). Assays with 
PTP plus APM showed several fold higher activity com- 
pared to PTP alone (Table 1, column 2) indicating that 
PTP cleaves at the NH,-terminal side of basic residue(s). 
Cleavage at the NH,-terminal side of basic residue(s) 
was calculated as activity detected in the presence of 
APM, minus the activity in the absence APM. Compar- 
ison of cleavage at COOH- and NH,-terminal sides 
showed that with monobasic substrates, PTP cleaves 
both sides of the basic residue (Fig. 2a). Preference for 
cleaving at either NH*- or COOH-terminal sides appears 
to depend on the particular monobasic peptide substrate. 
However, with all dibasic peptide-MCA substrates 
Table 1 
Hydrolysis of peptide-MCA substrates by PTP, without and with amin- 
opeptidase M 
3. Results 
Substrate Proteolytic activity 
@mol AMUh/mg) 
3.1. PTP cleavage spec$city with monobasic and dibasic 
peptide-MCA substrates 
PTP cleavage of several monobasic and dibasic pep- 
tide-MCA substrates was highest with the monobasic 
substrates Z-Phe-Arg-MCA and Bz-Val-Leu-Lys-MCA 
(Table 1, column 1). PTP activity was 1.7-fold higher 
with Z-Phe-Arg-MCA than with Bz-Val-Leu-Lys-MCA. 
PTP also cleaved Bz-Arg-MCA and Boc-Gln-Gly-Arg- 
MCA, while AC-Lys-MCA was not cleaved. 
PTP cleaved the dibasic peptide-MCA substrates Z- 
Arg-Arg-MCA, Boc-Gln-Arg-Arg-MCA, Boc-Gly-Arg- 
Arg-MCA, Z-Arg-Val-Arg-Arg-MCA, Boc-Gly-Lys- 
Arg-MCA, and Boc-Glu-Lys-Lys-MCA (Table 1, col- 
umn l), but with lower activity than with the monobasic 
peptides Z-Phe-Arg-MCA and Bz-Val-Leu-Lys-MCA. 
PTP cleaved substrates containing Arg-Arg, Lys-Arg, 
and Lys-Lys pairs with similar levels of activity (same 
order of magnitude). Arg in the P4 position [ 161 of Z-Arg- 
-APM +APM 
Monobasic: 
1. Z-Phe-Arg-MCA 
2. Bz-Arg-MCA 
3. Boc-Gln-Gly-Arg-MCA 
4. Bz-Val-Leu-Lys-MCA 
5. AC-Lys-MCA 
Dibasic: 
1. Z-Arg-Arg-MCA 
2. Boc-Gln-Arg-Arg-MCA 
3. Boc-Gly-Arg-Arg-MCA 
4. Z-Arg-Val-Arg-Arg-MCA 
5. Boc-Gly-Lys-Arg-MCA 
6. Boc-Glu-Lys-Lys-MCA 
1,176 
6 
695 
0 
16 
15 
19 
21 
7 
1,915 
24 
84 
885 
3 
49 
118 
42 
50 
73 
26 
PTP (5 &assay) activity was measured with peptide-MCA substrates 
(25 PM) in the absence and presence of aminopeptidase M (APM), as 
described in section 2. Control assays showed that these NH,-termi- 
nally blocked peptide-MCA substrates were not cleaved by APM alone, 
and the amount of APM (2 &assay) was sufficient to completely 
hydrolyze Arg-MCA (25 ,uM). 
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Peptide fr Tl 
YGGFMKKMDELYPLEVEEEANGGEVLGKRyGGF!d 
SAM-22P 
YGGFMkRVG’RPEWWMDYQk!RYG 
Peptide E 
7 7 
YGGFMRRVGRPEWWMDYQKRYGGFI. 
Fig. 1. PTP cleavage sites within enkephalin-containing peptides. (a) 
Proenkephalin-derived intermediates BAM-22P, peptide F, and peptide 
E are indicated. The bioactive peptides are represented by: M, 
(Met)enkephalin (Tyr-Gly-Gly-Phe-Met); L, (Leu)enkephalin (Tyr- 
Gly-Gly-Phe-Leu); 0, M-A&-Gly’-Leu’; H, M-Arg6-Phe’; K, Lys; R, 
Arg. (b) Major PTP cleavage sites [l-3] within peptide F, BAM-22P, 
and peptide E are indicated by arrows. The sequence of 
(Met)enkephalin, the final product of proenkephalin processing, is un- 
derlined. Paired basic residues (KR, KK, RR) and monobasic (R) 
cleavage sites are indicated by bold letters. 
tested, PTP clearly prefers to cleave at the NH,-terminal 
side of the basic residues (Fig. 2b). PTP cleavage of 
Z-Arg-Arg-MCA at the NH,-terminal side or between 
Arg-Arg was 2-fold greater than at the COOH-terminal 
side of dibasic site (Fig. 2b). Boc-Gln-Arg-Arg-MCA 
showed 7-fold greater cleavage at the NH,-terminal side 
of basic residues compared to the COOH-terminal side 
(Fig. 2b). 
3.2. Kinetics with Z-Phe-Arg-MCA as substrate 
PTP showed the highest level of activity with Z-Phe- 
Arg-MCA compared to all other monobasic and dibasic 
peptide substrates tested (Table 1). Therefore, to assess 
PTP’s affinity (K,J and maximal velocity (I’,,) for Z- 
Phe-Arg-MCA, PTP activity was measured at different 
concentrations of Z-Phe-Arg-MCA (Fig. 3). PTP dem- 
onstrated a K,,, of 8 PM and a V,,, of 5.3 mm01 AMC/ 
h/mg with Z-Phe-Arg-MCA. 
3.3. Effect of active site-directed peptide inhibitors 
Active site-directed peptide inhibitors can provide in- 
formation concerning the specificity of the protease for 
specific recognition of amino acid residues at and near 
the cleavage site of peptide substrates. For studies of the 
effect of peptide inhibitors, PTP activity was measured 
with Z-Phe-Arg-MCA as substrate (100 PM). PTP was 
potently inactivated by the irreversible chloromethane 
and diazomethane peptide inhibitors (o-Tyr)-Glu-Phe- 
Lys-Arg-CH,Cl, Z-Leu-Val-Gly-CHN,, and Z-Arg-Leu- 
Val-Gly-CHN*, as shown by plots of the rates of PTP 
inactivation (Fig. 4). Calculation of the second-order 
rate constant k,, indicated rapid rates of PTP inactiva- 
tion by these peptide inhibitors (Table 2). 
Inhibition by (o-Tyr)-Glu-Phe-Lys-Arg-CH,CI pro- 
vided further evidence for the specificity of PTP for the 
paired basic residues Lys-Arg. Very potent inhibition of 
PTP by Z-Arg-Leu-Val-Gly-CHN, and Z-Leu-Val-Gly- 
CHN2 (k2 values of 308,000 and 220,000 M-’ . s-l, re- 
spectively) is consistent with the observation that these 
peptides resemble PTP’s cleavage site, Val-GlyiArg, 
within the enkephalin-containing peptides BAM-22P 
and peptide E [2,3]. These results suggest PTP recogni- 
tion of the Val-Gly-Arg sequence. In addition, the se- 
quences of Z-Arg-Leu-Val-Gly-CHN, and Z-Leu-Val- 
Gly-CHN, correspond to the Arg8-Le$-ValiO-Gly,i seg- 
a 
Monobasic Peptides 
1200 
m NH)-Terminal S1do 
1 
loo0 
q COOH-Terminal Side 
p 300 
i- 
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b 
Dibasic Peptides 
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Fig. 2. PTP cleavage at NH,- and COOH-terminal sides of basic resi- 
dues. (a) Monobasic peptides. Cleavage at NH,-terminal (filled bars) 
and COOH-terminal (hatched bars) sides of basic residues are repre- 
sented by PTP activity with APM minus PTP activity without APM, 
and PTP activity without APM, respectively. Monobasic peptides num- 
bered l-5 are Z-Phe-Arg-MCA, Bz-Arg-MCA, Boc-Gln-Gly-Arg- 
MCA, Bz-Val-Leu-Lys-MCA, and AC-Lys-MCA, respectively (as indi- 
cated in Table 1). (b) Dibasic peptides. Cleavage at NH,-terminal (filled 
bars) and COOH-terminal (hatched bars) sides of dibasic peptides are 
represented by PTP activity with APM minus PTP activity without 
APM, and PTP activity without APM, respectively. Dibasic peptides 
numbered l-6 are Z-Arg-Arg-MCA, Boc-Gln-Arg-Arg-MCA, Boc- 
Gly-Arg-Arg-MCA, Z-Arg-Val-Arg-Arg-MCA, Boc-Gly-Lys-Arg- 
MCA, and Boc-Glu-Lys-Lys-MCA, respectively (as indicated in Table 
1). All experiments were performed three times (in duplicate) and the 
average of PTP activity is indicated; values from triplicate experiments 
varied by less than 10%. 
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Fig. 3. Lineweaver-Burk plot of PTP with Z-Phe-Arg-MCA. PTP (0.1 
@assay) was assayed with different concentrations of substrate Z-Phe- 
Arg-MCA [S]. Kinetic constants & and V,,,., were determined by l/v 
vs. l/S. 
ment of cystatin C that is essential for selective inhibition 
of cysteine proteases [18-201, thus, confirming PTP as a 
cysteine protease. 
4. Discussion 
Investigation of the cleavage specificity of the ‘pro- 
hormone thiol protease’ (PTP) with peptide-MCA sub- 
strates revealed that PTP cleaves at monobasic (Arg and 
Lys) and paired basic (Arg-Arg, Lys-Arg, Lys-Lys) resi- 
dues. At monobasic sites, PTP cleaved at both the 
COOH- and NH,-terminal sides of the single Arg and 
Lys residues, with preference for either side of the basic 
residue dependent on the particular peptide substrate. 
Among the monobasic peptides tested, PTP showed 
highest activity with Z-Phe-Arg-MCA. Also, PTP seems 
to prefer mono-arginyl compared to mono-lysyl sub- 
strates. At dibasic sites, PTP clearly prefers to cleave at 
the NH,-terminal side or between the pair of basic resi- 
dues, with a much lower degree of cleavage at the 
COOH-terminal side of the paired basic residues. These 
results show that PTP’s cleavage specificity is consistent 
with its role in processing the enkephalin precursor [ 1,3] 
and possibly other prohormones at paired basic and 
monobasic residues flanking the bioactive peptide within 
its precursor. 
Importantly, these results indicate that PTP’s cleavage 
specificity differs from that of other prohormone proc- 
essing proteases, including the subtilisin-related propro- 
tein convertases PC1/3 [5-71 and PC2 [7,8], as well as the 
‘proopiomelanocortin converting enzyme’ (PCE) [9]. In 
contrast to PTP, PC1/3 and PC2 in co-transfection ex- 
periments cleave prohormones at the COOH-terminal 
side of paired basic residues [21-231. Also, PC1/3 cleaves 
on the COOH-terminal side of a single Arg [24]. In addi- 
tion, furin, another subtilisin-related processing pro- 
tease, cleaves at the COOH-terminal side of the Arg-X- 
Lys/Arg-Arg motif [ 171. The PCE aspartyl protease from 
bovine pituitary intermediate lobe [9] cleaves dibasic sites 
of proopiomelanocortin (POMC) between and at the 
COOH-terminal side of paired basic residues. Recently, 
a yeast aspartyl proteinase encoded by the YAP3 gene 
was shown to be involved in processing pro-&-mating 
factor in KEXZdeficient mutants [25]. Yeast aspartyl 
protease, YAP3, also cleaves paired basic residues of 
mammalian POMC [26] and angler&h prosomatostatin- 
I [27] between and at the COOH-terminal side of dibasic 
residues, as well as at the COOH-terminal side of a mon- 
obasic site of prosomatostatin-II [27]. Clearly, the cleav- 
age site specificity of PTP differs from other processing 
enzymes. 
Comparison of PTP with several other putative mono- 
basic-cleaving processing enzymes indicates that PTP is 
the only cysteine protease that cleaves at both monobasic 
and paired basic residues at an acidic pH of 5.0-5.5, 
which is consistent with the intragranular environment 
of pH 5.5-5.8 [l-3]. A putative dynorphin-converting 
activity represented by a thiol protease cleaves dynor- 
phin B29 at either side of Arg14, but does not cleave the 
dibasic Arg-Arg site within dynorphin B29 [28], and, 
therefore, differs from PTP. Monobasic-cleaving serine 
proteases involved in processing prosomatostatin [29] 
and procholecystokinin [30] also differ from PTP since 
they preferentially cleave at the COOH-terminal side of 
monobasic residues. These comparisons illustrate that 
PTP differs from previously reported monobasic-cleav- 
ing proteases that may be involved in prohormone proc- 
essing. 
Inhibition of proteases by active site-directed chlo- 
romethyl ketone and diazomethane peptide inhibitors 
provides knowledge of protease specificity for the P, 
position and can indicate residues at the P,, P,, or P4 
positions that may be involved in substrate binding. The 
P, residue refers to the amino acid at the NH,-terminal 
side of the cleaved peptide bond, and Pz to P4 are adja- 
cent to P1 [16]. Inhibition of PTP by (D-Tyr)-Glu-Phe- 
Table 2 
Effect of peptide inhibitors on PTP activity 
Inhibitors (concentration) kz (M-i . s-‘) 
(n-Tyr)-Glu-Phe-Lys-Arg-CH,CI (lo-’ M) 10,312 
Z-Leu-Val-Gly-CHN, (3 x lo-’ M) 220,000 
Z-Arg-Leu-Val-Gly-CHN, (3 x lo+’ M) 308,000 
Second order rate constant, k2, was computed from plots of inactivation 
of PTP by these peptide inhibitors in Fig. 4, as described in section 2. 
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Fig. 4. Inactivation of PTP by peptide inhibitors. Inactivation of PTP by (o-Tyr)-Glu-Phe-Lys-Arg-CH,CI (lo-’ M), Z-Leu-Val-Gly-CHN, (3 
M), and Z-Arg-Leu-Val-Gly-CI-INNz (3 x 10e9 M) as a function of time of preincubation of PTP with each inhibitor is shown in panels a, b, 
respectively. 
Lys-Arg-CH,Cl provides additional support for PTP’s 
specificity for the dibasic Lys-Arg site. Potent inhibition 
of PTP by Z-Leu-Val-Gly-CHN, and Z-Arg-Leu-Val- 
Gly-CHN2 suggests the involvement of Val-Gly in PTP 
binding to peptide substrates. These results are consis- 
tent with PTP cleavage of BAM-22P and peptide E at the 
Val-Gly%rg sequence (Fig. 1) [2,3]. It is also important 
to note that Z-Leu-Val-Gly-CHN, and Z-Arg-Leu-Val- 
Gly-CHN2 are selective and potent inhibitors of cysteine 
proteases, since their peptide sequences are identical to 
the protease binding domain of the natural cysteine pro- 
tease inhibitor, cystatin C [l&20]. Thus, in addition to 
results of previous studies [l], inhibition of PTP by these 
cystatin C-related peptide inhibitors provides further 
support for PTP as a cysteine protease. 
Subsequent to endoproteolytic processing of pro- 
hormones, resultant peptide intermediates require re- 
moval of COOH- and NH,-terminal residues by car- 
boxypeptidase H (CPH, also known as carboxypeptidase 
E or enkephalin convertase) [31,32] and an aminopepti- 
dase [33], respectively. However, prohormone intermedi- 
ates generated by PTP cleavage at the NH,-terminal side 
of dibasic or monobasic residues would require only an 
aminopeptidase, and not CPH, for further processing. 
Our finding of PTP as the major enkephalin precursor 
processing enzyme in chromaffin granules suggests that 
CPH may not be necessary for processing all proenkeph- 
alin-derived intermediates. Results of this study also in- 
dicate that PTP could generate peptides possessing X- 
Gly at their COOH-terminus that may serve as sub- 
strates for peptidylglycine a-amidating monooxygenases 
(PAM) [34]. Many neuropeptides require COOH-termi- 
nal a-amidation for biological activity. Future studies of 
the co-regulation of PTP, aminopeptidase, CPH, and 
PAM will be important in understanding how PTP par- 
ticipates in the post-translational processing of pro- 
hormones. 
x 1o-g 
and c, 
In summary, use of peptide-MCA substrates and ac- 
tive site-directed peptide inhibitors demonstrates that 
PTP possesses unique cleavage site specificity compared 
to other prohormone processing enzymes. These results 
provide further evidence for PTP as a novel prohormone 
processing enzyme belonging to the class of cysteine pro- 
teases. 
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